Zdrowie i gospodarka · 07/11/2017

FDA Releases Guidance for Industry on Aspirin Labeling for Cardiovascular Risk

The FDA has issued a guidance for industry to encourage the safe use of over-the-counter aspirin products by requiring manufacturers to include a statement reminding consumers to consult their healthcare provider before using aspirin for heart-related issues.